image
Arbutus Biopharma Corporation ABUS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.64
0.276 %
$ 690 M
Market Cap
-8.47
P/E
BALANCE SHEET
144 M ASSETS
-26.11%
Growth Rates
1Year -26.11%
3Years 1.75%
5Years -8.72%
7Years -8.83%
10Years 7.25%
38.4 M LIABILITIES
-34.46%
Growth Rates
1Year -34.46%
3Years 3.01%
5Years 6.74%
7Years -8.76%
10Years 11.85%
106 M EQUITY
-22.53%
Growth Rates
1Year -22.53%
3Years 1.31%
5Years -11.94%
7Years -8.86%
10Years 6.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Arbutus Biopharma Corporation
image
Current Assets 132 M
Cash & Short-Term Investments 126 M
Receivables 1.78 M
Other Current Assets 4.25 M
Non-Current Assets 12.4 M
Long-Term Investments 6.28 M
PP&E 6.09 M
Other Non-Current Assets 0
Current Liabilities 22.5 M
Accounts Payable 3.22 M
Short-Term Debt 850 K
Other Current Liabilities 18.4 M
Non-Current Liabilities 15.9 M
Long-Term Debt 8.3 M
Other Non-Current Liabilities 7.6 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
ASSETS
Cash & Cash Equivalents 26.3 30.8 109.3 52.3 31.8 36.9 54.3 23.4 166.8 72.2 68.7 47.0 9.0 12.3 23.3 21.5 21.1 4.9 10.5 25.0 35.6 20.5 25.6 2.0 10.9 0.8
Short Term Investments 99.7 116.1 46.0 71.0 59.0 87.7 72.1 107.1 14.5 40.0 0 0 0 0 0 4.7 0 0 0 0 3.6 17.7 21.9 21.9 8.7 5.7
Receivables 1.8 1.4 0.9 1.3 1.2 1.4 0.9 0.7 1.4 2.5 0.3 3.5 1.2 3.7 1.3 0.8 1.8 0.6 0.3 1.8 0.4 0.5 2.0 0.8 0.5 0.2
Inventory 0 (2.9) (4.4) (3.1) 0 0 0 1 1.1 0 1.0 (2.0) 1 0.2 0 0.1 0.2 1 2 0.3 0 1 1 0.2 1 1
Other Current Assets 3.6 2.9 8.9 6.2 3.6 3.2 2.5 1.6 1.2 1.8 1.3 0.8 1.2 1.5 0.2 0.2 0.2 0.1 0.4 1.9 1.0 0.2 0.2 0.2 71.2 K 0.3
Total Current Assets 132.0 151.1 160.7 127.7 93.8 129.2 129.4 132.6 183.9 116.4 70.3 51.2 11.6 17.9 24.8 27.3 23.3 5.5 10.9 28.7 40.1 38.9 49.8 25.2 20.2 6.8
PP&E 6.1 6.8 8.1 9.3 11.4 10.2 12.2 6.9 3.2 1.8 1.4 1.4 2.2 3.1 2.7 2.1 1.5 0.5 1.0 3.4 4.1 3.7 2.8 2.4 2.9 3.0
Intangible Assets 0 0 0 0 0 43.8 58.6 99.4 352.6 0 0 0 0 0 14.5 12.9 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 22.5 24.4 24.4 162.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 6.3 37.4 35.7 0 0 22.2 12.6 12.6 10.1 0 0 0 0 0 0 0 0 0 0 0.6 1.5 2.1 2.2 0.2 0.2 0.2
Other Long Term Assets 0 0.1 61 K 44 K 0.3 22.2 12.6 12.6 0 0 0 0 0 0 0 1 0 0 0 1.2 0.2 1 15.0 4.9 5.7 6.0
Other Assets 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 1 1 1 1 1 1
Total Assets 144.4 195.4 204.5 137.1 105.5 227.9 237.2 275.9 712.3 118.2 71.7 52.6 13.7 21.0 41.9 42.3 24.8 6.0 18.5 41.1 50.7 53.2 67.6 32.5 28.8 15.8
LIABILITIES
Accounts Payable 3.2 3.5 3.2 3.0 2.4 3.2 2.0 3.2 2.6 2.0 1.2 0.8 1.3 0 2.0 0.5 0.3 0.3 1.3 0.9 0 0 0 0 0 0
Short Term Debt 0.8 0.7 0.8 0.8 0.7 0 0 0 0 0 0 0 0 0 0 0 0.2 83.1 K 49.6 K 0.8 0.4 0.1 0.1 54.6 K 34.3 K 0
Other Current Liabilities 9.9 20.5 7.3 5.8 4.8 8.0 9.9 7.4 7.1 12.4 11.3 7.0 2.7 6.2 3.4 3.2 1.3 1.3 0.1 9.2 4.1 4.7 2.5 1.9 1.3 0.8
Total Current Liabilities 22.5 32.9 11.2 9.5 7.8 10.0 11.9 10.6 10.6 14.4 12.5 11.0 6.8 8.1 6.5 4.1 6.5 5.8 2.2 10.9 4.5 4.8 2.6 1.9 1.3 0.8
Long Term Debt 8.3 1.8 2.2 2.6 3.0 0 12.0 12.0 0 0 0 0 0 0 0 0 0 65 K 85.5 K 1.0 0.8 0.2 0.2 73.9 K 63.4 K 0
Deferred Tax Income 0 0 0 0 (19.0) 12.7 16.9 41.2 146.3 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0 0 0
Other Liabilities 7.6 17.9 21.6 23.0 3.0 3.8 28.1 50.3 7.5 0 0 0 0 0 0 0 0 0 34.7 32.3 2.0 2.6 2.7 0.5 0.5 0.6
Total Liabilities 38.4 58.6 35.0 35.1 32.8 27.7 54.7 72.9 164.6 30.2 12.5 11.7 8.5 10.3 6.5 4.1 6.5 5.9 37.0 51.6 7.3 7.9 6.1 2.5 1.9 1.4
EQUITY
Common Stock 1 349.8 1 318.7 1 286.6 985.9 898.5 879.4 876.1 867.4 834.2 290.0 216.7 239.5 10 333.0 10 333.0 0 0 197.2 154.6 155.2 149.9 138.1 96.1 94.8 68.2 56.9 35.0
Retained Earnings (1 276.7) (1 203.8) (1 134.3) (1 046.0) (970.1) (805.2) (738.1) (651.1) (267.0) (205.9) (167.0) (230.2) (253.5) (248.9) (211.9) (174.3) (199.8) (167.5) (191.4) (177.1) (142.5) (79.6) (50.6) (38.2) (30.0) (20.5)
Other Accumulative Comprehensive Income/Loss (48.4) (50.5) (48.3) (48.2) (48.2) (48.2) (48.2) (49.8) (49.8) (22.3) (15.8) (13.0) (16.1) (15.6) (11.9) (11.6) 0 0 0 0 0 0 0 0 0 0
Total Equity 106.0 136.9 169.4 102.0 72.7 200.2 182.5 203.0 547.7 88.0 59.2 40.9 5.2 10.7 35.4 38.3 18.4 0.2 (18.5) (10.5) 43.4 45.3 61.5 30.0 26.9 14.4
Total Liabilities and Equity 144.4 195.4 204.5 137.1 105.5 227.9 237.2 275.9 712.3 118.2 71.7 52.6 13.7 21.0 41.9 42.3 24.8 6.0 18.5 41.1 50.7 53.2 67.6 32.5 28.8 15.8
SHARES OUTSTANDING
Common Shares Outstanding 166.0 150.9 106.2 75.8 57.1 55.3 54.7 53.1 45.4 21.6 15.3 13.7 11.3 10.3 10.3 8.1 4.8 3.9 7.7 7.7 7.1 6.6 5.1 4.9 2.8 2.2